2120. Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model

BACKGROUND: Fluconazole is lifesaving for the treatment and prevention of cryptococcosis; however, optimal dosing is unknown. Initial fluconazole doses of 100 mg to 2000 mg/day have been used. Prevalence of fluconazole non-susceptible Cryptococcus is increasing over time, risking the efficacy of lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Chesdachai, Supavit, Rajasingham, Radha, Nicol, Melanie R, Meya, David, Bongomin, Felix, Abassi, Mahsa, Skipper, Caleb, Kwizera, Richard, Rhein, Joshua, Boulware, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809647/
http://dx.doi.org/10.1093/ofid/ofz360.1800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809647/
http://dx.doi.org/10.1093/ofid/ofz360.1800

Ejemplares similares